<DOC>
	<DOC>NCT01809665</DOC>
	<brief_summary>This investigation is designed to provide supporting evidence for the clinical safety of the Ilesto/Iforia ICD (implantable cardioverter-defibrillator)system and the Evia/Entovis HF-T (Heart Failure) triple chamber pacemaker system when used under specific MRI (magnetic resonance imaging) conditions.</brief_summary>
	<brief_title>ProMRI PROVEN Master Study</brief_title>
	<detailed_description />
	<criteria>Written informed consent Able and willing to complete MRI testing Able and willing to activate and use the Cardio Messenger Able and willing to complete all testing required by the clinical protocol Available for all followup visits at the investigational site Standard indication for single, dual, or triple chamber ICD or CRTP. ICD or CRTP system to be implanted in the pectoral region Patient body height ≥ 140 cm Age ≥ 18 years Standard contraindication for single, dual, or triple chamber ICD or CRTP. Systems with an atrial lead: The patient has persistent (lasting longer than 7 days or requiring cardioversion) or permanent atrial arrhythmia Patient has other medical implants that may interact with MRI, e.g. abandoned pacemaker/ICD leads, lead extensions, mechanical valves, other active medical devices, nonMRI compatible devices Patient has other metallic artifacts / components in body that may interact with MRI Life expectancy of less than eight months Cardiac surgery in the next eight months Pregnant or breastfeeding Enrolled in another nonobservational cardiac clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>ICD therapy</keyword>
	<keyword>CRT-P therapy</keyword>
	<keyword>MRI</keyword>
</DOC>